DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Kashiwagi A, Kazuta K, Yoshida S. et al.
Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus.
J Diabetes Investig 2014;
5: 382-391
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.